Skip to main content
Search

NYU Langone Health

6 related articles

Subscribe to updates
  1. One routine ER question may be enough: PREVIA's LLM ensemble forecasts PTSD risk a month after trauma

    Emergency departments rarely have time for PTSD screening. PREVIA feeds the transcript of a patient's answer to the routine question "What brought you to the ED?" into a clinically informed ensemble of Llama, Mistral and DeepSeek models arranged in three layers: four clinical dimensions are assessed first, synthesized into a structured summary, then combined with age, sex and trauma type into a 0–100 risk score with a short explanation. Among 145 trauma survivors at two New York City level-1 trauma centers, the ensemble reached AUROC 78.49%±5.75% and sensitivity 95.4%±3.99% for one-month PTSD diagnosis; on 30 randomly selected narratives it scored AUROC 84.39% versus 83.86% for an emergency clinician specialized in PTSD.

  2. medRxiv

    Focal dystonia gene hunt gets a new entry point: DystoniaGeneNet flags familial MRI signatures, then three new genes

    Isolated focal dystonia has fewer than five known causal genes, and small families with incomplete penetrance make linkage analysis hard. A 3D convolutional network, DystoniaGeneNet, judged familial status from T1-weighted brain MRI and correctly classified 18 of 21 independent familial cases (85.7%), then guided exome variant prioritization and segregation analysis in 214 individuals. Rare variants segregating with disease emerged in RAP1GAP, TNN and ITSN2, all converging on perisynaptic extracellular matrix–synapse signalling.

  3. A 45-member modified Delphi consensus: screen for eating disorders before GLP-1 receptor agonist prescribing, and generally avoid these agents in active anorexia and bulimia nervosa

    Using a three-round modified Delphi method, a 45-member panel of clinicians and researchers in diabetes, obesity and/or eating disorders plus people with lived experience reached an average 91.7% consensus on recommendations for GLP-1 receptor agonist use in eating disorder contexts, covering pre-treatment screening, risk-stratified monitoring, standardized educational materials and concurrent evidence-based psychotherapy, stating that these agents should generally be avoided in active eating disorders, particularly anorexia nervosa, atypical anorexia nervosa and bulimia nervosa with marked dietary restraint and/or significant weight suppression, and setting out research priorities in epidemiology, regulation and binge eating disorder trials.

  4. arXiv

    NeuroSymb-MRG generates radiology reports via differentiable abductive reasoning and active uncertainty minimization, raising BLEU-1 to 0.602 on IU X-ray and 0.487 on MIMIC-CXR

    The work presents NeuroSymb-MRG, a framework that maps image features to probabilistic clinical concepts, composes multi-hop abductive reasoning chains through a differentiable logic layer (product t-norm AND, probabilistic sum OR, learnable gating α), decodes those chains into roughly 120 clause templates augmented with retrieved evidence and constrained LLM paraphrasing, and drives clinician-in-the-loop review with active sampling based on rule-level predictive entropy (5 MC-dropout passes) plus k-center diversity (k=16 per round); on IU X-ray and MIMIC-CXR it improves BLEU-1 through BLEU-4, ROUGE-L and METEOR over the listed representative baselines, for example IU X-ray BLEU-1 of 0.602 and MIMIC-CXR BLEU-1 of 0.487.

  5. medRxiv

    Simulating Community Health Behavior with LLM Synthetic Populations: A Cross-State Evaluation of LLMPopSim

    The study introduces LLMPopSim, a generative population simulation framework that integrates U.S. Census and CDC data to construct synthetic individuals and uses an LLM to simulate individual health behaviors whose aggregate outcomes can be evaluated at the community level; developed with historical Hawaiʻi data and evaluated for temporal and geographic generalizability using held-out 2022 cohorts from Hawaiʻi and New York State with colorectal cancer screening and mammography as proof-of-concept behaviors, the four state-outcome evaluations showed mean absolute error of 3.5 to 15.0 percentage points and correlations between simulated and observed ZCTA-level prevalence of 0.26 to 0.69.

  6. Drug Resistance in Cancer: A Conceptual Shift from Single-Gene Mechanisms to Systemic Adaptive Resistance

    This review proposes reframing multidrug resistance (MDR) from conventional single-gene mechanism models toward systemic adaptive resistance as a complex and evolving biological phenomenon, and systematically reviews classical resistance mechanisms (drug uptake/efflux, compensatory pathway activation, apoptosis evasion), non-genetic resistance mechanisms (drug-tolerant persisters, DTPs; epithelial-mesenchymal transition, EMT; cancer stem cell, CSC, plasticity and related factors), how interactions among these mechanisms contribute to tumor persistence and MDR evolution, and translational barriers together with emerging pharmacological strategies including longitudinal molecular monitoring and artificial intelligence (AI)-assisted drug resistance prediction.

You’re all caught up